Atlas Trials

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Clinical trial NCT05139134 · UNKNOWN

Trial details

NCT number
NCT05139134
Sponsor
Sohag University
Status
UNKNOWN
Study type
OBSERVATIONAL
Urinary Bladder Urothelial Carcinoma
Start date
2022-01-01
Primary completion
2022-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.